Cargando…
MITD1 Deficiency Suppresses Clear Cell Renal Cell Carcinoma Growth and Migration by Inducing Ferroptosis through the TAZ/SLC7A11 Pathway
Clear cell renal cell carcinoma (ccRCC), the major histopathological subtype of renal cancer, is sensitive to ferroptosis. MIT-domain containing protein 1 (MITD1) has been reported to play an important role in hepatocellular carcinoma, while it remains unclear whether MITD1 is involved in ccRCC. Bas...
Autores principales: | Zhang, Ye, Li, Yanze, Qiu, Qiangmin, Chen, Zhiyuan, Du, Yang, Liu, Xiuheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9423985/ https://www.ncbi.nlm.nih.gov/pubmed/36046690 http://dx.doi.org/10.1155/2022/7560569 |
Ejemplares similares
-
A prognosis model for clear cell renal cell carcinoma based on four necroptosis-related genes
por: Qiu, Qiangmin, et al.
Publicado: (2022) -
Energy-Stress-Mediated AMPK Activation Promotes GPX4-Dependent Ferroptosis through the JAK2/STAT3/P53 Axis in Renal Cancer
por: Li, Yanze, et al.
Publicado: (2022) -
Prognostic Impact of MITD1 and Associates With Immune Infiltration in Kidney Renal Clear Cell Carcinoma
por: Chen, Chujie, et al.
Publicado: (2021) -
MITD1 is recruited to midbodies by ESCRT-III and participates in cytokinesis
por: Lee, Seongju, et al.
Publicado: (2012) -
Pan-Cancer Analysis of the Prognostic and Immunotherapeutic Value of MITD1
por: Dong, Shiqiang, et al.
Publicado: (2022)